PH30474A - Anit-atherosclerotic use of 17 alpha-dihydroequilin - Google Patents

Anit-atherosclerotic use of 17 alpha-dihydroequilin

Info

Publication number
PH30474A
PH30474A PH47563A PH47563A PH30474A PH 30474 A PH30474 A PH 30474A PH 47563 A PH47563 A PH 47563A PH 47563 A PH47563 A PH 47563A PH 30474 A PH30474 A PH 30474A
Authority
PH
Philippines
Prior art keywords
dihydroequilin
alpha
anit
ester
sulfate
Prior art date
Application number
PH47563A
Other languages
English (en)
Inventor
Steven J Adelman
Kurt E Steiner
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/157,661 external-priority patent/US5482935A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of PH30474A publication Critical patent/PH30474A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
PH47563A 1993-01-05 1993-12-28 Anit-atherosclerotic use of 17 alpha-dihydroequilin PH30474A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77793A 1993-01-05 1993-01-05
US08/157,661 US5482935A (en) 1993-01-05 1993-12-01 Anti-atherosclerotic use of 17 alpha-dihydroequilin

Publications (1)

Publication Number Publication Date
PH30474A true PH30474A (en) 1997-05-28

Family

ID=26668138

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47563A PH30474A (en) 1993-01-05 1993-12-28 Anit-atherosclerotic use of 17 alpha-dihydroequilin

Country Status (17)

Country Link
EP (1) EP0678027B1 (he)
JP (1) JP3344585B2 (he)
CN (1) CN1071573C (he)
AT (1) ATE209495T1 (he)
AU (1) AU6015794A (he)
CA (1) CA2152187A1 (he)
CY (1) CY2361B1 (he)
DE (1) DE69331237T2 (he)
DK (1) DK0678027T3 (he)
ES (1) ES2165382T3 (he)
HK (1) HK1011282A1 (he)
IL (1) IL108155A (he)
MX (1) MX9400254A (he)
PH (1) PH30474A (he)
PT (1) PT678027E (he)
SG (1) SG52359A1 (he)
WO (1) WO1994015612A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507889A (en) * 1968-06-11 1970-04-21 American Home Prod Process for the preparation of 17alpha-dihydroequilenin and related compounds
US3608075A (en) * 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4379780A (en) * 1980-09-29 1983-04-12 American Home Products Corporation 17 α-Dihydroequilin hapten and assay method

Also Published As

Publication number Publication date
IL108155A0 (en) 1994-04-12
WO1994015612A1 (en) 1994-07-21
SG52359A1 (en) 1998-09-28
EP0678027B1 (en) 2001-11-28
AU6015794A (en) 1994-08-15
CY2361B1 (en) 2004-06-04
CN1096443A (zh) 1994-12-21
MX9400254A (es) 1994-08-31
DE69331237T2 (de) 2002-06-13
JPH08505392A (ja) 1996-06-11
PT678027E (pt) 2002-04-29
ATE209495T1 (de) 2001-12-15
CA2152187A1 (en) 1994-07-21
IL108155A (he) 1999-08-17
CN1071573C (zh) 2001-09-26
EP0678027A1 (en) 1995-10-25
DK0678027T3 (da) 2002-03-18
HK1011282A1 (en) 1999-07-09
JP3344585B2 (ja) 2002-11-11
DE69331237D1 (de) 2002-01-10
ES2165382T3 (es) 2002-03-16

Similar Documents

Publication Publication Date Title
MY110734A (en) Improvements in or relating to dioic acids.
CA2213339A1 (en) Method of treating adenosine depletion
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
TW325996B (en) Anti-atherosclerotic composition containing 17α-dihydroequilin
AU5267698A (en) Ascending-dose dosage form
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
IL105329A0 (en) Halomethylidene derivatives and method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a s-phase or m-phase specific antineoplastic agent
AU3139097A (en) Methods of preventing skeletal problems in poultry
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
GR3034186T3 (en) 3,4-diarylchromans for treatment of dermatitis
MY121623A (en) Methods of preventing breast cancer.
AU573262B2 (en) Covalently bound heparin-antithrombin iii complex
EP0711169A4 (en) ANDROSTANTEROIDS AS A NEUROCHEMICAL INITIATORS OF A CHANGE IN HUMAN HUMAN FUNCTION AND RELATED PHARMACEUTICAL PREPARATIONS AND METHODS
HU9503579D0 (en) Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PH30474A (en) Anit-atherosclerotic use of 17 alpha-dihydroequilin
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
AU5278799A (en) Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof andpharmaceutical preparations containing said compounds
UA41376C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
UA19610A (uk) Спосіб лікуваhhя опісторхозhої іhвазії
MY104932A (en) Immunomodulatory azaspiranes
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
TW360538B (en) Pharmaceutical composition containing 4'-iodo-4'-deoxydoxorubicin for treatment of amyloidosis
UA28288A (uk) Спосіб лікування шизофренії
HU9902219D0 (en) Process for the treatment of retching and sexual dysfunction by use of benz [cd]indole-6-carboxamides